Sterling Capital Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.69K | Buy |
547
+223
| +69% | +$689 | ﹤0.01% | 2957 |
|
|
2025
Q1 | $1.13K | Sell |
324
-125
| -28% | -$436 | ﹤0.01% | 2776 |
|
|
2024
Q4 | $1.47K | Buy |
449
+288
| +179% | +$942 | ﹤0.01% | 2861 |
|
|
2024
Q3 | $620 | Buy |
+161
| New | +$620 | ﹤0.01% | 2772 |
|
|
2015
Q2 | – | Sell |
-14,263
| Closed | -$249K | – | 872 |
|
|
2015
Q1 | $249K | Buy |
+14,263
| New | +$249K | ﹤0.01% | 814 |
|